Chakrabarti Arunaloke, Kaur Harsimran, Rudramurthy Shivaprakash M, Appannanavar Suma B, Patel Atul, Mukherjee Kanchan K, Ghosh Anup, Ray Ujjwayini
Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
Med Mycol. 2016 Feb;54(2):111-9. doi: 10.1093/mmy/myv091. Epub 2015 Oct 18.
Brain abscess caused by Cladophialophora bantiana is a rare disease associated with high mortality due to delay in diagnosis and absence of standardized therapy. We reviewed 124 culture proven C. bantiana brain abscess cases; 103 cases published in English literature during 1952 through 2014 and 21 unpublished cases from our reference center. The majority (57.3%) of the patients was from Asian countries especially from India (62/124, 50%). The diagnosis of the cases was delayed with mean duration 115 days after developing symptoms. The disease was nearly equally distributed in immunocompetent and immunosuppressed hosts but associated with significantly higher mortality (77.1%) in later group. Complete excision of brain lesion in immunocompetent host led to significantly better survival (43.7%). Though all commercially available antifungal drugs have been used in these patients, amphotericin B deoxycholate or lipid preparations were most commonly (62.83%) prescribed agent. None of the drugs used was found to be independently associated with improved outcome. In vitro antifungal susceptibility testing of 13 isolates of our center, demonstrated good activity to voriconazole, posaconazole, and itraconazole, but these triazoles were prescribed in only 29.2% patients. Increased awareness with early suspicion of the disease, and aggressive medical and surgical approach in treating these patients may improve the outcome.
由班替枝孢霉引起的脑脓肿是一种罕见疾病,由于诊断延迟和缺乏标准化治疗,死亡率很高。我们回顾了124例经培养证实的班替枝孢霉脑脓肿病例;其中103例发表于1952年至2014年的英文文献,21例来自我们参考中心的未发表病例。大多数患者(57.3%)来自亚洲国家,尤其是印度(62/124,50%)。这些病例的诊断延迟,症状出现后平均持续115天。该疾病在免疫功能正常和免疫抑制宿主中分布几乎相同,但在后者中死亡率显著更高(77.1%)。免疫功能正常宿主的脑病变完全切除导致生存率显著提高(43.7%)。尽管所有市售抗真菌药物都已用于这些患者,但两性霉素B脱氧胆酸盐或脂质制剂是最常用的处方药物(62.83%)。未发现所使用的任何药物与改善预后独立相关。我们中心对13株分离菌进行的体外抗真菌药敏试验表明,伏立康唑、泊沙康唑和伊曲康唑具有良好活性,但仅29.2%的患者使用了这些三唑类药物。提高对该病的早期怀疑意识,并对这些患者采取积极的内科和外科治疗方法,可能会改善预后。